MAGNOLIA NEUROSCIENCES
Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small molecule therapeutics for the prevention of neuronal cell death, thereby providing novel treatment options for patients suffering from neurodegeneration and related conditions. Magnolia Neurosciences Corporation, created to pursue technologies developed at The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery Division and the Neurodegeneration Consortium (NDC), is a New York-based Accelerator Life Science Partner portfolio company.
MAGNOLIA NEUROSCIENCES
Industry:
Biotechnology Health Care Neuroscience Wellness
Founded:
2018-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.magnolianeurosciences.com
Total Employee:
1+
Status:
Active
Contact:
646-828-5990
Email Addresses:
[email protected]
Total Funding:
49.39 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF WordPress Apache Wordpress Plugins Euro Microsoft Exchange Online Office 365 Mail Google Maps
Current Employees Featured
Founder
Investors List
MD Anderson Cancer Center
MD Anderson Cancer Center investment in Series A - Magnolia NeuroSciences
180 Degree Capital
180 Degree Capital investment in Series A - Magnolia NeuroSciences
Watson Fund
Watson Fund investment in Series A - Magnolia NeuroSciences
Accelerator Life Science Partners
Accelerator Life Science Partners investment in Series A - Magnolia NeuroSciences
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Magnolia NeuroSciences
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Magnolia NeuroSciences
WuXi AppTec
WuXi AppTec investment in Series A - Magnolia NeuroSciences
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Magnolia NeuroSciences
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Magnolia NeuroSciences
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Magnolia NeuroSciences
Official Site Inspections
http://www.magnolianeurosciences.com Semrush global rank: 6.03 M Semrush visits lastest month: 1.35 K
- Host name: gra.graphicainc.com
- IP address: 162.241.142.33
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Magnolia NeuroSciences"
Magnolia NeuroSciences - Crunchbase Company Profile & Funding
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death. View contacts for Magnolia NeuroSciences to access new …See details»
Magnolia NeuroSciences - Craft
See insights on Magnolia NeuroSciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Magnolia Neuroscience - VentureRadar
Website: http://magnolianeurosciences.com/ Develops medicines protecting the nervous system from damage in Alzheimer's, Parkinson's, traumatic brain injury, and chemotherapy-related …See details»
Magnolia Neurosciences - PitchBook
Developer of novel therapeutics designed to treat neurodegeneration and neuronal injuries.See details»
Magnolia Neurosciences - Products, Competitors, Financials, …
Magnolia Neurosciences is a drug discovery and development company specializing in neuroprotective medicines within the pharmaceutical industry. Its main focus is on creating …See details»
Magnolia Neurosciences - Company Profile & Staff Directory
Magnolia Neurosciences Corporation is a drug discovery and development company focused on the creation of a novel class of neuroprotective medicines. The company was launched by a …See details»
Magnolia Neurosciences - LinkedIn
Magnolia Neurosciences | 374 followers on LinkedIn. Magnolia Neurosciences Corporation is a drug discovery and development company focused on the creation of a novel class of …See details»
Overview, News & Similar companies - ZoomInfo.com
Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small molecule therapeutics for the prevention of neurona l cell death, thereby providing novel …See details»
Magnolia NeuroSciences | Company | Mindmaps
Magnolia NeuroSciences discovers and develops drug-like small molecule therapeutics for the prevention of neuronal cell death.See details»
Accelerator Life Science Partners Launches Magnolia …
Aug 13, 2018 · NEW YORK-- ( BUSINESS WIRE )--Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it …See details»
Magnolia Neurosciences Corp. - Drug pipelines, Patents ... - Patsnap
Explore Magnolia Neurosciences Corp. with its drug pipeline, therapeutic area, technology platform, 1 news, and 1 literature.See details»
Magnolia Neurosciences Company Information - Funding, …
Get information on funding, investors, industries, and more for Magnolia Neurosciences. See Magnolia Neurosciences company profile and funding data.See details»
Accelerator Life Science Partners Launches Magnolia ... - BioSpace
Aug 13, 2018 · NEW YORK--(BUSINESS WIRE)-- Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it …See details»
Magnolia Neurosciences Corporation | Insights
Oct 4, 2018 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Accelerator Life Science Partners Launches Magnolia …
NEW YORK, NY – August 13, 2018 – Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Magnolia …See details»
Magnolia Neurosciences Corporation Announces that its …
Aug 27, 2018 · The company also has a wholly owned subsidiary, Magnolia Tejas Corporation, based in Houston, Texas that is focused on developing a novel therapy for chemotherapy …See details»
MD Anderson and Accelerator Life Science Partners Launch …
Aug 13, 2018 · The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, today announcedSee details»
Magnolia Neurosciences - CB Insights
Margarita has lead investments in over a dozen biotech companies in the US and Europe. She is responsible for AbbVie Ventures’ investments in Alector (NASDAQ: ALEC), Morphic …See details»
Magnolia Neuroscience | VentureRadar
Similar Companies: Genentech USA Publicly Traded Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people …See details»